[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1987

Hypopigmentation, Vitiligo, and MelanomaNew Data, More Enigmas

Author Affiliations

Department of Dermatology University of Cincinnati College of Medicine 231 Bethesda Ave, ML #592 Cincinnati, OH 45267

Arch Dermatol. 1987;123(8):1005-1008. doi:10.1001/archderm.1987.01660320047009
Abstract

Melanomas are a malignant proliferation of melanocytes. The disease vitiligo is a manifestation of a pathologic destruction of melanocytes. That the two diseases should occur together in the same patient seems to be an enigma. Why should some melanocytes in a given patient proliferate without control and metastasize while others are being destroyed? Yet the two diseases commonly have been associated (extensive bibliographies are provided in the reference sections of the articles in references 1 and 2). It seems that individuals with melanomas who also have vitiligolike depigmentation survive longer than patients with melanomas alone.1,2 It has been suggested that chemically induced depigmentation of patients with a high-risk melanoma (ie, thick Breslow or Clark levels) before metastases occurred would lessen the probability of recurrence or at least prolong the time before metastases were detectable.3

Two sets of investigators have studied "large groups" of patients; 51 patients in the

First Page Preview View Large
First page PDF preview
First page PDF preview
×